PASTEUR INSTITUT TUNIS has a total of 20 patent applications. Its first patent ever was published in 2001. It filed its patents most often in Tunisia, China and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, biotechnology and environmental technology are ASTRALIS LLC, ALLEGHENY UNIVERSITY OF THE HE and WUHAN MORE BIOTECHNOLOGY CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | Tunisia | 3 | |
#2 | China | 2 | |
#3 | WIPO (World Intellectual Property Organization) | 2 | |
#4 | Brazil | 1 | |
#5 | Canada | 1 | |
#6 | Czechia | 1 | |
#7 | EPO (European Patent Office) | 1 | |
#8 | France | 1 | |
#9 | Croatia | 1 | |
#10 | Hungary | 1 | |
#11 | Israel | 1 | |
#12 | Japan | 1 | |
#13 | Mexico | 1 | |
#14 | New Zealand | 1 | |
#15 | Poland | 1 | |
#16 | Yugoslavia (Serbia and Montenegro) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Environmental technology | |
#4 | Measurement | |
#5 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Medical preparations | |
#3 | Climate change adaptation technologies | |
#4 | Therapeutic chemical compounds | |
#5 | Microorganisms | |
#6 | Analysing materials | |
#7 | Enzymes |
# | Name | Total Patents |
---|---|---|
#1 | Chenik Mehdi | 11 |
#2 | Dellagi Koussay | 11 |
#3 | Louzir Hechmi | 11 |
#4 | Ben Achour Yosser | 8 |
#5 | Achour Yosser Ben | 3 |
#6 | Koussay Dellagi | 2 |
#7 | Hechmi Louzir | 1 |
#8 | Benabdesselem Chaouki | 1 |
#9 | Issam Hmila | 1 |
#10 | Makram Essafi | 1 |
Publication | Filing date | Title |
---|---|---|
WO2019186344A1 | Anti-cancer and disintegrin scorpion venoms | |
TN2013000198A1 | Use of foxo3 activators to prevent/treat tuberculosis in mammals | |
TNSN08251A1 | Agents and derivative conjugate or chimeric complexes neutralizing toxicity of venom plypeptides | |
CA2591804A1 | Method for preparing recombinant mycobacterial polypeptides in yeast and their use in diagnosis of mycobacterial related diseases | |
TNSN05214A1 | Novel agents to neutralize toxicity of venom polypeptides | |
FR2826018A1 | Gene associated with the virulence of parasite leishmania |